AnalystsUmer RaffatUmer Raffat's Stock Forecasts
AnalystsUmer Raffat
Analyst Ranking
Bottom 9%
#5049 out of 5510 analysts
Average Return
-4.73%
Win Rate
50%12 out of 24
Risk vs Reward
Poor
Good
Umer Raffat's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Metsera IncMTSR | +157.96% | $27.33 | $70.50 | 2025-02-25 - 2025-11-14 | Buy |
Teva Pharmaceutical Industries LtdTEVA | +97.22% | $8.26 | $16.29 | 2023-05-18 - 2024-05-17 | Buy |
Amylyx Pharmaceuticals IncAMLX | +75.77% | $22.41 | $39.39 | 2022-02-02 - 2023-02-01 | Buy |
Centessa Pharmaceuticals PLCCNTA | +60.07% | $5.69 | $9.10 | 2023-06-21 - 2024-06-21 | Buy |
Legend Biotech CorpLEGN | +32.22% | $50.53 | $66.81 | 2022-11-02 - 2023-11-01 | Buy |
Umer Raffat Analyst Color
Get additional color on Umer Raffat's coverage of popular stocks
Umer Raffat's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Apnimed IncAPMD | 1 | Buy | N/A | N/A | Initiates Coverage On | 22 days ago |
AlvotechALVO | 1 | Buy | N/A | N/A | Initiates Coverage On | a month ago |
Biogen IncBIIB | 1 | Buy | N/A | N/A | Reinstates | 4 months ago |
Kailera Therapeutics IncKLRA | 1 | Buy | N/A | N/A | Initiates Coverage On | 4 months ago |
Metsera IncMTSR | 1 | Buy | N/A | N/A | Initiates Coverage On | 2 years ago |
Spyre Therapeutics IncSYRE | 1 | Buy | N/A | N/A | Initiates Coverage On | 2 years ago |
Amylyx Pharmaceuticals IncAMLX | 2 | Hold | N/A | N/A | Downgrades | 3 years ago |
Fractyl Health IncGUTS | 1 | Buy | N/A | N/A | Initiates Coverage On | 3 years ago |
Rapt Therapeutics IncRAPT | 1 | Buy | N/A | N/A | Initiates Coverage On | 3 years ago |
Alkermes PLCALKS | 1 | Buy | N/A | N/A | Upgrades | 3 years ago |
Centessa Pharmaceuticals PLCCNTA | 1 | Buy | N/A | N/A | Initiates Coverage On | 3 years ago |
Teva Pharmaceutical Industries LtdTEVA | 1 | Buy | N/A | N/A | Upgrades | 3 years ago |
Phathom Pharmaceuticals IncPHAT | 2 | Buy | N/A | N/A | Upgrades | 3 years ago |
Mineralys Therapeutics IncMLYS | 1 | Buy | N/A | N/A | Initiates Coverage On | 4 years ago |
Legend Biotech CorpLEGN | 1 | Buy | N/A | N/A | Initiates Coverage On | 4 years ago |
Cerevel Therapeutics Holdings IncCERE | 1 | Buy | N/A | N/A | Initiates Coverage On | 4 years ago |
Organon & CoOGN | 1 | Buy | N/A | N/A | Initiates Coverage On | 5 years ago |
Kodiak Sciences IncKOD | 1 | Buy | N/A | N/A | Initiates Coverage On | 6 years ago |
Vor Biopharma IncVOR | 1 | Buy | $960.00 | N/A | Initiates Coverage On | 6 years ago |
Amgen IncAMGN | 1 | Buy | N/A | N/A | Upgrades | 7 years ago |
Palvella Therapeutics IncPVLA | 1 | Buy | $1,040.00 | N/A | Initiates Coverage On | 8 years ago |
Dicerna Pharmaceuticals IncDRNA | 1 | Buy | $14.00 | N/A | Initiates Coverage On | 9 years ago |
Dermira IncDERM2 | 1 | Buy | $48.00 | N/A | Initiates Coverage On | 9 years ago |
Jazz Pharmaceuticals PLCJAZZ | 1 | Strong Buy | N/A | N/A | Initiates Coverage On | 10 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.